Mark Identification

CAELIMIR

Serial Number

79406277

Filing Date

Aug 8, 2024

Trademark by

TOXGENSOLUTIONS BV

Classification Information

Software relating to the pharmaceutical field; bioinformatics software; healthcare software; software relating to the medical field; software relating to research, discovery and development of pharmaceuticals, therapeutics and/or diagnostics; electronic databases for capturing, storing, processing, evaluating and reproducing pharmaceutical data; all of the aforementioned goods whether or not including artificial intelligence.

Electrical and Scientific Apparatus

Providing temporary use of non-downloadable software for capturing, storing, processing, evaluating and reproducing pharmaceutical data; software as a service (SaaS) featuring health monitoring software; software as a service (SaaS) featuring bioinformatics software; scientific computer programming services; pharmaceutical research and development; research and development of mRNA-based therapeutics; research and development of mRNA-based diagnostics; research and development of mRNA drugs; research and development in the field of microorganisms and cells; pharmaceutical products development; pharmaceutical product evaluation; testing of pharmaceuticals; development of gene-based medicines; laboratory research services relating to pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to research and development in the field of therapeutics; services for assessing the efficiency of pharmaceuticals; information technology services for the pharmaceutical and healthcare industries; conducting early evaluations in the field of new pharmaceuticals; chemical research and analysis services; medical and pharmacological research services; scientific research for medical purposes; research and development in the field of diagnostic preparations; genetic research; genetic mapping for scientific purposes; providing scientific information in the field of medical disorders and their treatment; biotechnological research; biochemical research and development; research and development of vaccines; pharmaceutical drug discovery and development services; all of the aforementioned services whether or not including artificial intelligence; platform as a Service (PaaS), Software as a Service (SaaS) and/or Data as a Service (DaaS) in relation to all the aforementioned services.

Computer and Scientific